Ross I. Baker is a hematologist based in Perth, WA. His practice address is on Monash Avenue, Perth, and he works with people who need help with blood conditions and clotting problems.
Blood issues can be confusing, and they can show up in lots of ways. Some patients come in with bleeding or bruising, while others are dealing with clotting in veins, like deep vein thrombosis (DVT) or pulmonary embolism. Over time, this sort of problem can affect day-to-day life, so a clear plan and careful follow-up really matters.
Ross also looks after people with blood disorders that change how blood cells work. This can include anaemia, low platelets (thrombocytopenia), and different types of purpura. At times, people are managing immune-related conditions such as adult immune thrombocytopenia (ITP) or problems like von Willebrand disease (VWD). He helps sort out what’s going on and what treatment steps usually make the most sense.
Clotting risks are another big part of his work. He treats conditions linked to higher risk of venous thromboembolism (VTE), including factor V Leiden thrombophilia and antiphospholipid syndrome. These can need long-term thinking, especially because medicines and monitoring plans may change depending on test results and how symptoms evolve.
Some patients also present with rarer blood-related conditions. Ross works through complex cases such as hemolytic anaemias and haemolytic-uraemic syndrome (HUS), including atypical and D-minus types, as well as related variants. He may also be involved in care for people with haemophilia A or haemophilia B, where bleeding control and medication timing can be very important.
He also sees people with blood cancers and slow-growing conditions, including multiple myeloma and smouldering multiple myeloma. And in recent years, some patients with long COVID have sought support for ongoing symptoms that can overlap with blood and clotting concerns, so this is something he looks at as part of broader care.
For education, Ross has completed medical training and continued learning in the field of hematology. He stays up to date with current treatment approaches and research updates, so care can reflect what’s known now, not just what was known years ago.
If clinical trials are relevant, they’re considered case by case as part of the bigger treatment picture, based on what fits the person’s situation and test results.